Estimating baseline creatinine levels based on the kidney parenchymal volume
Clinical and Experimental Nephrology · 2024
DOI: 10.1007/s10157-024-02526-2 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Clinical and Experimental Nephrology, 2024. Verfasst von Takaya Sasaki und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-Ku,…. Hauptthemen laut MEDLINE: Creatinine, Glomerular Filtration Rate, Kidney, Acute Kidney Injury. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
BACKGROUND: Acute kidney injury (AKI) diagnosis often lacks a baseline serum creatinine (Cr) value. Our study aimed to create a regression equation linking kidney morphology to function in kidney donors and chronic kidney disease patients. We also sought to estimate baseline Cr in minimal change disease (MCD) patients, a common AKI-predisposing condition. METHODS: We analyzed 119 participants (mean age 60 years, 50% male, 40% donors) with CT scans, dividing them into derivation and validation groups. An equation based on kidney parenchymal volume (PV) was developed in the derivation group and validated in the validation group. We estimated baseline Cr in 43 MCD patients (mean age 45 years, 61% male) using the PV-based equation and compared with their 6 month post-MCD onset Cr values. RESULTS: In the derivation group, the equation for the estimated glomerular filtration rate (eGFR) was: eGFR (mL/min/1.73m2) = 0.375 × PV (cm3) + (- 0.395) × age (years) + (- 2.93) × male sex + (- 13.3) × hypertension + (- 14.0) × diabetes + (- 0.210) × height (cm) + 82.0 (intercept). In the validation group, the eGFR and estimated Cr values correlated well with the measured values (r = 0.46, p = 0.01; r = 0.51, p = 0.004, respectively). In the MCD group, the baseline Cr values were significantly correlated with the estimated baseline Cr values (r = 0.52, p < 0.001), effectively diagnosing AKI (kappa = 0.76, p < 0.001). CONCLUSIONS: The PV-based regression equation established in this study holds promise for estimating baseline Cr values and diagnosing AKI in patients with MCD. Further validation in diverse AKI populations is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-Ku, Tokyo, Japan. h18ms-sasaki@jikei.ac.jp.
- Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-Ku, Tokyo, Japan.
- Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-Ku, Tokyo, Japan. tsuboi-n@jikei.ac.jp.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Sasaki, T., Tosaki, T., Kuno, H., Marumoto, H., Okabayashi, Y., Haruhara, K., Kanzaki, G., Koike, K., Kobayashi, A., Yamamoto, I., Tsuboi, N., & Yokoo, T. (2024). Estimating baseline creatinine levels based on the kidney parenchymal volume. Clinical and Experimental Nephrology. https://doi.org/10.1007/s10157-024-02526-2
Vancouver
Sasaki T, Tosaki T, Kuno H, Marumoto H, Okabayashi Y, Haruhara K, et al. Estimating baseline creatinine levels based on the kidney parenchymal volume. Clinical and Experimental Nephrology. 2024. doi:10.1007/s10157-024-02526-2
BibTeX
@article{Sasaki2024,
author = {Sasaki, Takaya and Tosaki, Takeshi and Kuno, Hideaki and Marumoto, Hirokazu and Okabayashi, Yusuke and Haruhara, Kotaro and Kanzaki, Go and Koike, Kentaro and Kobayashi, Akimitsu and Yamamoto, Izumi and Tsuboi, Nobuo and Yokoo, Takashi},
title = {Estimating baseline creatinine levels based on the kidney parenchymal volume},
journal = {Clinical and Experimental Nephrology},
year = {2024},
doi = {10.1007/s10157-024-02526-2}
}
EUVIMED